125 related articles for article (PubMed ID: 38838340)
21. Targeted acidosis mediated delivery of antigenic MHC-binding peptides.
Kelly JJ; Ankrom ET; Newkirk SE; Thévenin D; Pires MM
Front Immunol; 2024; 15():1337973. PubMed ID: 38665920
[TBL] [Abstract][Full Text] [Related]
22. Invariant chain as a vehicle to load antigenic peptides on human MHC class I for cytotoxic T-cell activation.
Wälchli S; Kumari S; Fallang LE; Sand KM; Yang W; Landsverk OJ; Bakke O; Olweus J; Gregers TF
Eur J Immunol; 2014 Mar; 44(3):774-84. PubMed ID: 24293164
[TBL] [Abstract][Full Text] [Related]
23. Selective elimination of antigen-specific line T cells and ex vivo antigen-primed lymph node cells by antigen-targeted drug-labeled antigen-presenting cell membranes.
Chang NH; Boggs JM
Cell Immunol; 1997 Mar; 176(2):135-45. PubMed ID: 9073386
[TBL] [Abstract][Full Text] [Related]
24. Intratumoral peptide injection enhances tumor cell antigenicity recognized by cytotoxic T lymphocytes: a potential option for improvement in antigen-specific cancer immunotherapy.
Nobuoka D; Yoshikawa T; Takahashi M; Iwama T; Horie K; Shimomura M; Suzuki S; Sakemura N; Nakatsugawa M; Sadamori H; Yagi T; Fujiwara T; Nakatsura T
Cancer Immunol Immunother; 2013 Apr; 62(4):639-52. PubMed ID: 23143746
[TBL] [Abstract][Full Text] [Related]
25. Major histocompatibility complex class I-intercellular adhesion molecule-1 association on the surface of target cells: implications for antigen presentation to cytotoxic T lymphocytes.
Lebedeva T; Anikeeva N; Kalams SA; Walker BD; Gaidarov I; Keen JH; Sykulev Y
Immunology; 2004 Dec; 113(4):460-71. PubMed ID: 15554924
[TBL] [Abstract][Full Text] [Related]
26. The human CD8 coreceptor effects cytotoxic T cell activation and antigen sensitivity primarily by mediating complete phosphorylation of the T cell receptor zeta chain.
Purbhoo MA; Boulter JM; Price DA; Vuidepot AL; Hourigan CS; Dunbar PR; Olson K; Dawson SJ; Phillips RE; Jakobsen BK; Bell JI; Sewell AK
J Biol Chem; 2001 Aug; 276(35):32786-92. PubMed ID: 11438524
[TBL] [Abstract][Full Text] [Related]
27. Generation of autologous cytotoxic and helper T-cell responses against the B-cell leukemia-associated antigen HB-1: relevance for precursor B-ALL-specific immunotherapy.
de Rijke B; Fredrix H; Zoetbrood A; Scherpen F; Witteveen H; de Witte T; van de Wiel-Van Kemenade E; Dolstra H
Blood; 2003 Oct; 102(8):2885-91. PubMed ID: 12842998
[TBL] [Abstract][Full Text] [Related]
28. Discrepancy between ELISPOT IFN-gamma secretion and binding of A2/peptide multimers to TCR reveals interclonal dissociation of CTL effector function from TCR-peptide/MHC complexes half-life.
Rubio-Godoy V; Dutoit V; Rimoldi D; Lienard D; Lejeune F; Speiser D; Guillaume P; Cerottini JC; Romero P; Valmori D
Proc Natl Acad Sci U S A; 2001 Aug; 98(18):10302-7. PubMed ID: 11517329
[TBL] [Abstract][Full Text] [Related]
29. Allogeneic GM-CSF-secreting tumor cell immunotherapies generate potent anti-tumor responses comparable to autologous tumor cell immunotherapies.
Li B; Simmons A; Du T; Lin C; Moskalenko M; Gonzalez-Edick M; VanRoey M; Jooss K
Clin Immunol; 2009 Nov; 133(2):184-97. PubMed ID: 19664962
[TBL] [Abstract][Full Text] [Related]
30. Coordinated responses to individual tumor antigens by IgG antibody and CD8+ T cells following cancer vaccination.
Hulett TW; Jensen SM; Wilmarth PA; Reddy AP; Ballesteros-Merino C; Afentoulis ME; Dubay C; David LL; Fox BA
J Immunother Cancer; 2018 Apr; 6(1):27. PubMed ID: 29618380
[TBL] [Abstract][Full Text] [Related]
31. [MHC tetramers: tracking specific immunity].
Kosor E; Gagro A; Drazenović V; Kuzman I; Jeren T; Rakusić S; Rabatić S; Markotić A; Gotovac K; Sabioncello A; Cecuk E; Kerhin-Brkljacić V; Gjenero-Margan I; Kaić B; Mlinarić-Galinović G; Kastelan A; Dekaris D
Acta Med Croatica; 2003; 57(4):255-9. PubMed ID: 14639858
[TBL] [Abstract][Full Text] [Related]
32. Generation of stable CD4+ and CD8+ T cell lines from patients immunized with ras oncogene-derived peptides reflecting codon 12 mutations.
Abrams SI; Khleif SN; Bergmann-Leitner ES; Kantor JA; Chung Y; Hamilton JM; Schlom J
Cell Immunol; 1997 Dec; 182(2):137-51. PubMed ID: 9514698
[TBL] [Abstract][Full Text] [Related]
33. Impact of CD8-MHC class I interaction in detection and sorting efficiencies of antigen-specific T cells using MHC class I/peptide multimers: contribution of pMHC valency.
Neveu B; Echasserieau K; Hill T; Kuus-Reichel K; Houssaint E; Bonneville M; Saulquin X
Int Immunol; 2006 Jul; 18(7):1139-45. PubMed ID: 16751231
[TBL] [Abstract][Full Text] [Related]
34. Induced sensitization of tumor stroma leads to eradication of established cancer by T cells.
Zhang B; Bowerman NA; Salama JK; Schmidt H; Spiotto MT; Schietinger A; Yu P; Fu YX; Weichselbaum RR; Rowley DA; Kranz DM; Schreiber H
J Exp Med; 2007 Jan; 204(1):49-55. PubMed ID: 17210731
[TBL] [Abstract][Full Text] [Related]
35. Liposomal vaccines--targeting the delivery of antigen.
Altin JG; Parish CR
Methods; 2006 Sep; 40(1):39-52. PubMed ID: 16997712
[TBL] [Abstract][Full Text] [Related]
36. Quantum dot/peptide-MHC biosensors reveal strong CD8-dependent cooperation between self and viral antigens that augment the T cell response.
Anikeeva N; Lebedeva T; Clapp AR; Goldman ER; Dustin ML; Mattoussi H; Sykulev Y
Proc Natl Acad Sci U S A; 2006 Nov; 103(45):16846-51. PubMed ID: 17077145
[TBL] [Abstract][Full Text] [Related]
37. Major histocompatibility complex (MHC) class II-peptide complexes arrive at the plasma membrane in cholesterol-rich microclusters.
Bosch B; Heipertz EL; Drake JR; Roche PA
J Biol Chem; 2013 May; 288(19):13236-42. PubMed ID: 23532855
[TBL] [Abstract][Full Text] [Related]
38. Normalized Synergy Predicts That CD8 Co-Receptor Contribution to T Cell Receptor (TCR) and pMHC Binding Decreases As TCR Affinity Increases in Human Viral-Specific T Cells.
Williams CM; Schonnesen AA; Zhang SQ; Ma KY; He C; Yamamoto T; Eckhardt SG; Klebanoff CA; Jiang N
Front Immunol; 2017; 8():894. PubMed ID: 28804489
[TBL] [Abstract][Full Text] [Related]
39. MediMer: a versatile do-it-yourself peptide-receptive MHC class I multimer platform for tumor neoantigen-specific T cell detection.
Meyer M; Parpoulas C; Barthélémy T; Becker JP; Charoentong P; Lyu Y; Börsig S; Bulbuc N; Tessmer C; Weinacht L; Ibberson D; Schmidt P; Pipkorn R; Eichmüller SB; Steinberger P; Lindner K; Poschke I; Platten M; Fröhling S; Riemer AB; Hassel JC; Roberti MP; Jäger D; Zörnig I; Momburg F
Front Immunol; 2023; 14():1294565. PubMed ID: 38239352
[TBL] [Abstract][Full Text] [Related]
40. Enhanced Detection of Antigen-Specific CD4+ T Cells Using Altered Peptide Flanking Residue Peptide-MHC Class II Multimers.
Holland CJ; Dolton G; Scurr M; Ladell K; Schauenburg AJ; Miners K; Madura F; Sewell AK; Price DA; Cole DK; Godkin AJ
J Immunol; 2015 Dec; 195(12):5827-36. PubMed ID: 26553072
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
